Translating Substance Use Research into Practice and Policy
What is CRISM?
The Canadian Research Initiative in Substance Misuse (CRISM) is a national network of researchers, service providers, policy makers and people with lived experience across Canada. Funded by the Canadian Institutes of Health Research (CIHR), CRISM's overall objective is to conduct research and translate it into evidence-based interventions for substance misuse, towards the improvement and creation of health system changes. Our intent is to support the creation of more effective, personal and adoptable intervention programs and services. The national CRISM website may be found here.
Established in 2015, CRISM is made up of four regional 'Nodes' across Canada, and is modeled after the U.S.-based Clinical Trials Network of the National Institute on Drug Abuse (NIDA). CRISM was established to facilitate communication and collaboration among addiction service providers, researchers and policy-makers Canada-wide. CRISM focuses on research on prevention and treatment interventions for substance misuse (primarily illicit drugs and non-medical use of pharmaceutical drugs), and knowledge translation of related research and evidence.
What is OCRINT?
OCRINT (the Ontario CRISM Node Team) is one of the four CRISM nodes, and is housed within the Institute for Mental Health Policy Research (IMHPR) at the Centre for Addiction and Mental Health (CAMH), in Toronto, Ontario. Led by Dr. Jürgen Rehm, senior scientist at IMHPR, and Professor and Chair (Addiction Policy), University of Toronto, OCRINT is made up of an interdisciplinary team of researchers, service providers, policy makers and peers, together with a team of co-principal investigators and knowledge users.
Other CRISM Nodes: